Global Biotechnology Market by Application (Bioinformatics, Health), by Technology (DNA Sequencing, Nanobiotechnology) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global biotechnology market value was USD 752.88 billion in 2020. It is expected to grow at a compound annual rate (CAGR of 15.83%) between 2021 and 2028. Due to the rapid growth of biotechnology in developing countries like India and China, the market is driven by government initiatives. The government initiatives focus on modernizing the drug regulatory system, standardizing clinical studies and improving reimbursement policies. This will provide lucrative growth opportunities for the market. Additionally, small molecules dominated the pipeline of pharmaceutical compounds in 2019, with 22 U.S. FDA approvals to date. This compares to eight large molecules (biotech) which had only 8. A growing number of orphan drugs and personalized medicines means that around 4 out 10 drugs are biotech-derived. This is driving the growth of innovative biotechnology companies and further increasing market revenue.

Agri-input companies also focus on improving existing technologies, including the development of new stacked genes in crops and new germplasm through breeding innovations and gene sequences. For improved productivity and sustainable solutions, companies are focusing their efforts on bringing new agricultural innovations to market. BASF, for instance, announced in February 2020 that it will launch over 30 projects to develop novel seeds, traits and biological crop protection solutions. The market growth is aided by the extensive use of biotechnology to improve agricultural products.

The COVID-19 pandemic is a positive catalyst for market growth. The leaders in developing drugs that target COVID-19 are biotech companies. Gilead Sciences, Inc. was granted FDA approval for antiviral Remdesivir in the treatment of COVID-19 patients, 8 months after the initial COVID-19 case.

The market is also growing due to increased involvement of the biotechnology sector with drug manufacturers, multinational pharmaceutical companies and diagnostic companies. Pfizer Inc. partnered with BioNTech SE in March 2020 to develop BNT162, a COVID-19 vaccine candidate. BioNTech SE created the vaccine using mRNA technology to accelerate the development of the COVID-19 vaccination.

Application Insights

In 2020, the health application segment accounted for 48.64% of the total market. This trend is expected to continue throughout the forecast period. The increasing incidence of diseases is the main reason for the segment's growth. The segment's growth is also due to an increased focus on agribiotech and providing services, growing adoption of bioinformatics solutions, and thriving bio-industrial sector.

Companies are also entering into partnerships to develop new therapeutic molecules. This is what is driving the market. Amgen partnered with Adaptive Biotechnologies in April 2020 to develop and discover antibodies that will combat the COVID-19 pandemic. The collaboration will utilize Adaptive's immune medicine platform to identify virus-neutralizing antibody and combine Amgen’s expertise in immunology and novel antibody therapy for promising new treatments against SARS-CoV-2.

Due to increasing alliances that coordinate and promote the adoption of informatics tools, the bioinformatics segment will grow at a 21.2% CAGR from 2021-2028. GC Pharma, for example, entered into a partnership in September 2020 with Atomwise to discover new methods of treating hemophilia. Both companies will be focusing on other treatment options than the replacement therapies commonly used to treat hemophilia. Atomwise's AI platform AtomNet screened 16 billion compounds in just two days.

Technology Insights

In 2020, the others technology segment accounted for 27.83% of the total market. In 2020, DNA sequencing accounted for the second largest share. Advanced DNA sequencing is responsible for the growth of this segment. In April 2020, for example, the Baylor College of Medicine Human Genome Sequencing Center was awarded a grant by the National Institutes of Health for the Pacific Biosciences Sequel IIDNA sequencing instrument. This will improve the efficiency and capability of sequencing. It can sequence through difficult regions of the human genome. This will enable comprehensive genome sequencing

Nanobiotechnology will grow at 16.8% CAGR between 2021 and 2028 due to technological advances in the field. For instance, in January 2021, Oxford Nanopore collaborated with NVIDIA for integrating NVIDIA DGX Station A100 in PromethION, the company's ultra-high-throughput sequencing system. This integration of AI and computing tools allows for faster and more accurate DNA and RNA sequencing, increasing availability of nanopore sequencing data.

Regional Insights

In 2020, North America was responsible for 44.19% of the total market share. Many factors are responsible for the growth of the region's market, including the presence of key players and extensive R&D activities. Also, high healthcare spending. The market is also growing due to an expanding number of drug approvals. Biogen Inc. was granted the U.S. FDA approval in February 2021 for PLEGRIDY (peginterferon alpha-1a), which is used to treat multiple sclerosis relapsing. This approval will expand the company's portfolio of multiple sclerosis treatments.

Asia Pacific will experience the fastest expansion rate of 16.8% between 2021 and 2028. The region's growth can be attributed to improved healthcare infrastructure, supportive policies by the government, clinical trials services and other epidemiological factors. For the sake of accelerating the growth of biotechnology, foreign companies have been collaborating extensively with local businesses. Bayer AG and Monsanto India entered into a USD 63 Billion merger agreement in September 2019. This led to Bayer CropScience Ltd being formed. This will allow Bayer to incorporate Monsanto’s knowledge in digital farming and seeds into its product portfolio.

Market Share Insights & Key Companies

Different business development strategies are used by companies to expand their product portfolio, including acquisitions, mergers and agreements. F. Hoffmann-La Roche Ltd. acquired Inflazome in September 2020. This Irish biotechnology company specializes in inflammasome inhibitions. This acquisition will grant the company the rights to Inflazome’s entire portfolio of small molecules of NLRP3 inhibitors, both clinically and preclinically. The company also plans to develop NLRP3 inhibitions that can be used for a variety of indications. The following are some of the major players in the global biotechnology industry:

• AstraZeneca

• Gilead Sciences, Inc.

• CELGENE CORPORATION

• Biogen

• Abbott

• Amgen Inc.

• Novo Nordisk A/S

• Merck & Co.

• Johnson & Johnson Services, Inc.

• Novartis AG

• Sanofi

• F. Hoffmann-La Roche Ltd.

• Pfizer, Inc.

• Lonza

Up Market Research published a new report titled “Biotechnology Market research report which is segmented by Application (Bioinformatics, Health), by Technology (DNA Sequencing, Nanobiotechnology), By Players/Companies Abbott, Merck & Co, Novartis AG, Lonza, Amgen Inc, Biogen, Gilead Sciences Inc  , AstraZeneca, Novo Nordisk A/S, Pfizer Inc, CELGENE CORPORATION, Sanofi, Johnson & Johnson Services Inc, F Hoffmann-La Roche Ltd”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Biotechnology Market Report Segments:

The market is segmented by Application (Bioinformatics, Health), by Technology (DNA Sequencing, Nanobiotechnology).

Biotechnology Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Biotechnology Market

Overview of the regional outlook of the Biotechnology Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Biotechnology Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Biotechnology Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Bioinformatics

                2. Health

                1. DNA Sequencing

                2. Nanobiotechnology

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Biotechnology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Biotechnology Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.